Inflammation
Research News and Information

Sunday, November 22, 2009

Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation.

6 Dec 2009 Chronic kidney disease (CKD) carries an increased risk of cardiovascular disease (CVD). Macrophage migration inhibiting factor (MIF) is a proinflammatory cytokine implicated in the pathogenesis of sepsis, autoimmune disease, atherogenesis, and ... Read more...

Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathways.

8 Nov 2009 S100A7 (psoriasin) is a member of the S100 family of signaling proteins. It is implicated in and considered a therapeutic target for inflammation and cancer, yet no small molecule ligands for S100A7 have been identified. To begin the development of ... Read more...

Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases.

30 Oct 2009 The nuclear factor-kappaB (NF-kappaB) signalling pathway regulates immune responses and is implicated in the pathogenesis of many inflammatory diseases. Given the well established pro-inflammatory functions of NF-kappaB, inhibition of this pathway ... Read more...

Latest indexed articles for 'Inflammation'

These are the very latest articles for this heading:

• Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation. 6 Dec 2009
• Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathways. 8 Nov 2009
• The microcytic red cell and the anemia of inflammation. 3 Nov 2009
• Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. 30 Oct 2009
• Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men. 30 Oct 2009
• Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease. 30 Oct 2009
• NF-kappaB independent activation of a series of proinflammatory genes by hydrogen sulfide. 30 Oct 2009
• Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer. 30 Oct 2009
• The effect of perioperative intravenous lidocaine on postoperative pain and immune function. 30 Oct 2009
• Temporomandibular joint pain and synovial fluid analysis: a review of the literature. 30 Oct 2009
• Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype. 30 Oct 2009
• Hyperglycemia and mechanical stress: targeting the renal podocyte. 30 Oct 2009
• Matrix metalloproteinase-8 and the regulation of blood pressure, vascular inflammation, and atherosclerotic lesion growth. 21 Oct 2009
• Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing. 19 Oct 2009
• Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. 18 Oct 2009
• Summaries for patients. Effect of treatment with fluticasone with and without salmeterol on airway inflammation and lung function in patients with chronic obstructive pulmonary disease: a randomized trial. 18 Oct 2009
• A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor. 18 Oct 2009
• Smad4: gatekeeper gene in head and neck squamous cell carcinoma. 17 Oct 2009
• Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. 17 Oct 2009
• Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10. 13 Oct 2009

See a longer list of these articles.

Technical information about 'Inflammation'

Definition: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.

Descriptor UI: D007249

Alternative terms: Inflammation; Inflammations;

Related Mesh Headings: Acute-Phase Reaction; Anti-Inflammatory Agents;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C23.550.470;

Technical Notes: IM general inflammatory process; look for specific inflamm dis in MeSH as -ITIS; NIM as coord for organ /dis not in MeSH as -ITIS; /drug ther: consider also ANTI-INFLAMMATORY AGENTS & its specifics; ACUTE PHASE REACTION (an early local inflammatory reaction to inj: see MeSH definition) is available; Manual 23.13+; DF: INFLAMM